Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ijcard.2013.11.073 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Letter to the editor: re-evaluating approaches: current issues in the treatment of adolescent idiopathic scoliosis.
Asian Spine J
December 2024
School of Health Sciences, Chhatrapati Shahu Ji Maharaj University, Kanpur, India.
Comment Regarding "The Influence of Arrhythmia on the Outcomes of Pediatric Patients with Idiopathic Dilated Cardiomyopathy".
Pediatr Cardiol
December 2024
Faculty of Medicine, Alexandria University, Alexandria, Egypt.
The article "The Influence of Arrhythmia on the Outcomes of Pediatric Patients with Idiopathic Dilated Cardiomyopathy" by Mohammad Dalili et al. provides valuable insights into the impact of arrhythmia on idiopathic dilated cardiomyopathy outcomes. However, it presents with certain limitations.
View Article and Find Full Text PDFTiming impact on the initiation of pirfenidone therapy on idiopathic pulmonary fibrosis disease progression.
World J Clin Cases
November 2024
Department of Clinical Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 343433, Egypt.
Article Synopsis
- * PFD is effective in managing IPF at various stages, showing antifibrotic, anti-inflammatory, and antioxidant benefits.
- * Although some patients may experience side effects and require dosage adjustments, PFD helps slow disease progression and improves overall patient outcomes, including reducing serious health events and mortality rates.
Axatilimab: First Approval.
Drugs
November 2024
Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.
Article Synopsis
- * In August 2024, Axatilimab received approval in the USA for treating cGVHD in patients who have not responded to at least two prior systemic therapies, applicable to both adults and children over 40 kg.
- * The article reviews the key milestones in the development of Axatilimab leading to its first approval for cGVHD treatment.
Beyond pharmacotherapy: bilateral adrenal artery embolization as a potential game-changer for idiopathic hyperaldosteronism patients.
Hypertens Res
January 2025
Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!